Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT
Ionis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 944.24M | 717.44M | 705.32M | 803.25M | 813.25M | 776M | 787.5M | 615M | 630.77M | 576.56M | 587.48M | 875.48M | 848.8M | 840.76M | 810.45M | 660.45M | 687.44M | 707.22M |
Cost of Revenue | 10.52M | 16.11M | 22.45M | 21.68M | 22.61M | 15.86M | 9.06M | 10M | 9.52M | 11.26M | 14.43M | 12.43M | 13.99M | 12.21M | 10.62M | 11.62M | 11.62M | 11.68M |
Gross Profit | 933.72M | 701.33M | 682.88M | 781.57M | 790.64M | 760.14M | 778.44M | 605M | 621.25M | 565.3M | 573.05M | 863.05M | 834.81M | 828.55M | 799.84M | 648.84M | 675.81M | 695.55M |
Operating Income | -266.52M | -472.43M | -475.08M | -370.38M | -364.73M | -389.64M | -354.12M | -556M | -472.14M | -466.65M | -410.13M | 18.87M | -7.84M | 4.71M | -29.79M | -273.79M | -224.48M | -203.26M |
Interest Income | 2.22M | 2.22M | 2.27M | 5.56M | 27.26M | 27.26M | 45.84M | 54.45M | 38.03M | 38.06M | 19.44M | 7.7M | 219K | 566K | 580K | 431K | 391K | 14K |
Pretax Income | -274.43M | -464.16M | -460.07M | -355.8M | -352.7M | -363.5M | -333.77M | -375M | -280.71M | -306.58M | -257.65M | 11.35M | -25.72M | -3.39M | -29.06M | -278.06M | -234.73M | -198.39M |
Net Income | -268.22M | -458.03M | -453.9M | -358.81M | -365.33M | -384.07M | -365.26M | -408M | -307.99M | -328.13M | -269.29M | 7.71M | -27.77M | -3.51M | -28.21M | -593.21M | -541.69M | -492.66M |
Selling & General & Admin | 316.55M | 285.48M | 256.23M | 239.13M | 247.53M | 233.99M | 233M | 209.9M | 174.3M | 162.1M | 150.2M | 140.3M | 136M | 147.3M | 170.3M | 271.3M | 309.65M | 336.56M |
Research & Development | 883.47M | 888.07M | 901.53M | 912.6M | 907.83M | 915.77M | 899.55M | 951M | 918.99M | 869.75M | 832.87M | 703.87M | 705.65M | 664.2M | 642.88M | 634.88M | 575.19M | 558.15M |
Other Expenses | 39K | 627K | 904K | 1.32M | 1.29M | 676K | 399K | n/a | n/a | n/a | 187K | 187K | -282K | -471K | -655K | -1.66M | -1.06M | -1.02M |
Operating Expenses | 1.2B | 1.17B | 1.16B | 1.15B | 1.16B | 1.15B | 1.13B | 1.16B | 1.09B | 1.03B | 983.17M | 844.17M | 841.65M | 811.5M | 813.18M | 906.18M | 884.84M | 894.71M |
Interest Expense | 88.27M | 89.81M | 87.44M | 85.43M | 86.18M | 83.34M | 79.9M | 60.78M | 40.94M | 21.79M | 5.47M | 5.98M | 6.18M | 5.38M | 6.08M | 15.35M | 15.43M | 17.88M |
Selling & Marketing Expenses | n/a | n/a | -5.65M | -5.65M | -5.65M | -5.75M | 384K | 384K | 384K | 484K | n/a | -600K | -600K | -600K | -600K | n/a | n/a | n/a |
Cost & Expenses | 1.21B | 1.19B | 1.18B | 1.17B | 1.18B | 1.17B | 1.14B | 1.17B | 1.1B | 1.04B | 997.6M | 856.6M | 855.65M | 823.71M | 823.79M | 917.79M | 896.46M | 906.39M |
Income Tax Expense | -6.53M | -6.44M | -6.48M | 3.01M | 12.63M | 20.57M | 31.5M | 33M | 27.28M | 21.54M | 11.64M | 3.94M | 2.35M | 417K | -547K | 317.15M | 321.11M | 320.34M |
Shares Outstanding (Basic) | 159.14M | 158.74M | 158M | 148.59M | 145.96M | 145.54M | 144M | 143.32M | 143.1M | 142.74M | 142M | 141.95M | 141.79M | 141.6M | 141M | 141.14M | 140.96M | 140.77M |
Shares Outstanding (Diluted) | 182.33M | 158.74M | 158M | 148.59M | 145.96M | 145.54M | 144M | 143.32M | 143.1M | 142.74M | 142M | 141.95M | 141.79M | 141.6M | 160M | 141.14M | 140.96M | 140.77M |
EPS (Basic) | -1.76 | -2.99 | -3.04 | -2.44 | -2.52 | -2.66 | -2.55 | -2.86 | -2.16 | -2.31 | -1.9 | 0.06 | -0.19 | -0.02 | -0.2 | -4.22 | -3.86 | -3.52 |
EPS (Diluted) | -1.84 | -2.99 | -3.04 | -2.44 | -2.52 | -2.66 | -2.55 | -2.86 | -2.16 | -2.31 | -1.9 | -0.12 | -0.37 | -0.2 | -0.38 | -4.22 | -3.86 | -3.52 |
EBITDA | -188.44M | -376.51M | -347.59M | -243.55M | -240.87M | -254.84M | -230.09M | -290.5M | -216.74M | -260.59M | -227.87M | 39.9M | 642K | 23.12M | -1.85M | -243.35M | -189.28M | -145.11M |
EBIT | -211.7M | -399.89M | -371.13M | -268.91M | -267.93M | -282.02M | -256.97M | -318.98M | -244.46M | -287.7M | -252.53M | 13.5M | -23.46M | -908K | -27.2M | -261.44M | -207.69M | -162.53M |
Depreciation & Amortization | 23.25M | 23.38M | 21.99M | 22.34M | 22.43M | 22.54M | 22.5M | 23.91M | 23.42M | 22.82M | 22.11M | 20.06M | 19.67M | 19.6M | 19.56M | 19.14M | 18.89M | 17.9M |